Open AccessResponse to Teriparatide in Patients with Baseline 25-Hydroxyvitamin D Insufficiency or Sufficiency
Author(s) -
Bess DawsonHughes,
Peiqi Chen,
John H. Krege
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-0239
Subject(s) - teriparatide , medicine , femoral neck , placebo , context (archaeology) , procollagen peptidase , vitamin d and neurology , osteoporosis , bone mineral , urology , randomization , parathyroid hormone , endocrinology , randomized controlled trial , surgery , calcium , paleontology , biology , alternative medicine , pathology
Serum 25-hydroxyvitamin D (25OHD) concentrations greater than 30 ng/ml have been recommended for lowering fracture risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom